ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Stock Income Statement
NASDAQ:ASBP - Nasdaq - US7389201077 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 16.12M | 3.09M | 1.34M | 980.00K | N/A | |||
| Selling, General, and Administrative Expenses | 15.86M | 3.09M | 1.34M | 980.00K | N/A | |||
| Operating Income | -16.12M | -3.09M | -1.34M | -980.00K | 0.00 | |||
| Interest Income/Expense | -962.70K | -342.90K | 5.80M | 4.32M | N/A | |||
| Other Income/Expense | N/A | -9.11M | N/A | N/A | N/A | |||
| Income Before Taxes | -26.01M | -12.54M | 4.46M | 3.34M | N/A | |||
| Net Income | -26.01M | -12.54M | 4.46M | 3.34M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.71 | -1.52 | 0.23 | 0.11 | N/A | |||
| Statistics | ||||||||
All data in USD